Evidence map›Paper›PMID 35747843›Full record

ArticleHemaSphere2022

European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera.

Douglas Tremblay, Andrew Srisuwananukorn, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L Heaney, Andrew Kuykendall, Casey L O'Connell, Jamile M Shammo, Angela Fleischman and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Cytoreduction for ET and PV: who, what, when, and how?Hematology. American Society of Hematology. Education Program · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Douglas TremblayTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Andrew SrisuwananukornTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Lukas RonnerDepartment of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Nikolai PodoltsevHematology Section, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
Jason GotlibStanford University Medical Center, Palo Alto, CA, USA.
Mark L HeaneyHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA.
Andrew KuykendallDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Casey L O'ConnellJane Anne Nohl Division of Hematology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
Jamile M ShammoDivision of Hematology/Oncology, Rush University Medical Center, Chicago, IL, USA.
Angela FleischmanUniversity of California, Irvine, CA, USA.
Ruben MesaUT Health San Antonio Cancer Center, San Antonio, TX, USA.
Abdulraheem YacoubThe University of Kansas Cancer Center, Leawood, KS, USA.
Ronald HoffmanTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Erin MoshierDepartment of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Nicole ZubizarretaDepartment of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
John MascarenhasTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Icahn School of Medicine at Mount Sinai · USColumbia University Irving Medical Center · USHospital of the University of Pennsylvania · USMoffitt Cancer Center · USRush University Medical Center · USStanford Medicine · USThe University of Kansas Cancer Center · USThe University of Texas Health Science Center at San Antonio · USUniversity of California, Irvine · USUniversity of Southern California · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35747843
PMCPMC9208865
OpenAlexW4280625521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.